RERAX | RIVKX | RERAX / RIVKX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 5 years | - |
Gain YTD | 6.544 | 7.636 | 86% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 131B | 2.1B | 6,235% |
Annual Yield % from dividends | 0.91 | 1.15 | 80% |
Returns for 1 year | 0.55 | 5.59 | 10% |
Returns for 3 years | -0.33 | 15.25 | -2% |
Returns for 5 years | 4.19 | 26.10 | 16% |
Returns for 10 years | 15.23 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYWTX | 73.13 | 1.48 | +2.07% |
Rydex Emerging Markets 2X Strategy A | |||
JFNIX | 71.71 | -0.51 | -0.71% |
Janus Henderson Global Life Sciences I | |||
WFATX | 39.07 | -0.34 | -0.86% |
Allspring Index Asset Allocation Instl | |||
NQGIX | 36.35 | -0.37 | -1.01% |
Nuveen Global Equity Income I | |||
GSVCX | 15.04 | -0.23 | -1.51% |
Goldman Sachs Large Cap Value C |